GlassScriptPhysician profile
Stacey S Roper
NPI 1063617439
$2,674.86
in general payments reported to CMS, 2019-2025
27 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $860 · 2022: $1,172 · 2023: $283 · 2024: $174 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570 · Education: $72.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.48 |
| Education | $72.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $852.89 | 2021-2025 | Tezspire, Breztri, Symbicort |
| Grifols USA, LLC | $377.25 | 2021-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.55 | 2021-2022 | |
| Glaxosmithkline, LLC. | $199.55 | 2021-2025 | Nucala |
| Paratek Pharmaceuticals, INC. | $107.12 | 2021-2022 | |
| Philips North America LLC | $106.32 | 2021-2023 | |
| Genzyme Corporation | $105.44 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.15 | 2021-2023 | Glassia |
| United Therapeutics Corporation | $64.45 | 2021-2023 | |
| Mylan Specialty L.P. | $60.09 | 2021-2022 | |
| Inogen, INC. | $58.46 | 2022-2024 | |
| Insmed, INC. | $48.71 | 2022-2025 | Arikayce |
| Baxter Healthcare | $46.69 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $41.30 | 2023-2024 | Dupixent |
| Advanced Respiratory, INC | $38.72 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $36.58 | 2022-2023 | Sunosi |
| Ethicon INC. | $35.04 | 2022 | |
| Genentech USA, INC. | $34.70 | 2022 | |
| Amgen INC. | $31.11 | 2022 | |
| Gilead Sciences, INC. | $28.42 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $25.29 | 2022 | |
| Verona Pharma, INC. | $24.99 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $20.10 | 2021 | |
| Phadia US INC. | $15.31 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $15.03 | 2022 | |
| Electromed, INC. | $12.85 | 2021 | |
| Inspire Medical Systems, INC. | $12.75 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Roper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.